HUMAW vs ROL
Humacyte Inc (HUMAW) versus Rollins Inc (ROL) — a side-by-side from cached financials, not a winner call.
Humacyte Inc (HUMAW) common stock listed on NASDAQ.
Rollins Inc (ROL) is a personal services company listed on NYSE.
HUMAW does not have a complete income-statement cache yet.
Latest reported ROL revenue for 2026-06-30 was $1.99B. Net income was $251.7M. ROL currently screens at market cap $21.73B and trailing P/E 41.4.
HUMAW currently screens at market cap $0. ROL currently screens at market cap $21.73B and trailing P/E 41.4.
Not investment advice. Open the HUMAW and ROL stock pages for the full models.
Not investment advice.